Targeted genome editing via engineered nucleases is an exciting area of biomedical research and holds potential for clinical applications. Despite rapid advances in the field, in vivo targeted transgene integration is still infeasible because current tools are inefficient1, especially for non-dividing cells, which compose most adult tissues. This poses a barrier for uncovering fundamental biological principles and developing treatments for a broad range of genetic disorders2. Based on clustered regularly interspaced short palindromic repeat/Cas9 (CRISPR/Cas9)3,4 technology, here we devise a homology-independent targeted integration (HITI) strategy, which allows for robust DNA knock-in in both dividing and non-dividing cells in vitro and, more importantly, in vivo (for example, in neurons of postnatal mammals). As a proof of concept of its therapeutic potential, we demonstrate the efficacy of HITI in improving visual function using a rat model of the retinal degeneration condition retinitis pigmentosa. The HITI method presented here establishes new avenues for basic research and targeted gene therapies.

  • Subscribe to Nature for full access:



Additional access options:

Already a subscriber?  Log in  now or  Register  for online access.


  1. 1.

    Gene therapy returns to centre stage. Nature 526, 351–360 (2015)

  2. 2.

    , & Therapeutic genome editing: prospects and challenges. Nat. Med. 21, 121–131 (2015)

  3. 3.

    et al. RNA-guided human genome engineering via Cas9. Science 339, 823–826 (2013)

  4. 4.

    et al. Multiplex genome engineering using CRISPR/Cas systems. Science 339, 819–823 (2013)

  5. 5.

    et al. Site-specific integration and tailoring of cassette design for sustainable gene transfer. Nat. Methods 8, 861–869 (2011)

  6. 6.

    et al. Targeted genome editing in human repopulating haematopoietic stem cells. Nature 510, 235–240 (2014)

  7. 7.

    , & Small fragment homologous replacement (SFHR): sequence-specific modification of genomic DNA in eukaryotic cells by small DNA fragments. Methods Mol. Biol . 1114, 85–101 (2014)

  8. 8.

    et al. A mechanism for the suppression of homologous recombination in G1 cells. Nature 528, 422–426 (2015)

  9. 9.

    The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway. Annu. Rev. Biochem. 79, 181–211 (2010)

  10. 10.

    , & Is non-homologous end-joining really an inherently error-prone process? PLoS Genet. 10, e1004086 (2014)

  11. 11.

    , , & Obligate ligation-gated recombination (ObLiGaRe): custom-designed nuclease-mediated targeted integration through nonhomologous end joining. Genome Res. 23, 539–546 (2013)

  12. 12.

    , , , & Highly efficient CRISPR/Cas9-mediated knock-in in zebrafish by homology-independent DNA repair. Genome Res. 24, 142–153 (2014)

  13. 13.

    et al. Microhomology-mediated end-joining-dependent integration of donor DNA in cells and animals using TALENs and CRISPR/Cas9. Nat. Commun. 5, 5560 (2014)

  14. 14.

    et al. Linear DNAs concatemerize in vivo and result in sustained transgene expression in mouse liver. Mol. Ther. 3, 403–410 (2001)

  15. 15.

    , , & Minicircle DNA vectors devoid of bacterial DNA result in persistent and high-level transgene expression in vivo. Mol. Ther. 8, 495–500 (2003)

  16. 16.

    , & The intracellular mobility of nuclear import receptors and NLS cargoes. Biophys. J. 96, 3840–3849 (2009)

  17. 17.

    , & Immunohistochemical localization of a neuron-specific β-tubulin isotype in the developing chicken ultimobranchial glands. Brain Res. 628, 121–127 (1993)

  18. 18.

    & Efficient in utero gene transfer system to the developing mouse brain using electroporation: visualization of neuronal migration in the developing cortex. Neuroscience 103, 865–872 (2001)

  19. 19.

    & Progenitors resume generating neurons after temporary inhibition of neurogenesis by Notch activation in the mammalian cerebral cortex. Development 132, 1295–1304 (2005)

  20. 20.

    et al. A robust and high-throughput Cre reporting and characterization system for the whole mouse brain. Nat. Neurosci. 13, 133–140 (2010)

  21. 21.

    & AAV-mediated gene therapy for research and therapeutic purposes. Annu. Rev. Virol . 1, 427–451 (2014)

  22. 22.

    et al. Effect of gene therapy on visual function in Leber’s congenital amaurosis. N. Engl. J. Med. 358, 2231–2239 (2008)

  23. 23.

    et al. Safety and efficacy of gene transfer for Leber’s congenital amaurosis. N. Engl. J. Med. 358, 2240–2248 (2008)

  24. 24.

    et al. Long-term safety and efficacy of factor IX gene therapy in hemophilia B. N. Engl. J. Med . 371, 1994–2004 (2014)

  25. 25.

    , , & Analysis of AAV serotypes 1–9 mediated gene expression and tropism in mice after systemic injection. Mol. Ther. 16, 1073–1080 (2008)

  26. 26.

    et al. Human retinal progenitor cell transplantation preserves vision. J. Biol. Chem. 289, 6362–6371 (2014)

  27. 27.

    et al. Mutation of the receptor tyrosine kinase gene Mertk in the retinal dystrophic RCS rat. Hum. Mol. Genet . 9, 645–651 (2000)

  28. 28.

    , , , & Millisecond-timescale, genetically targeted optical control of neural activity. Nat. Neurosci. 8, 1263–1268 (2005)

  29. 29.

    et al. Brains, genes, and primates. Neuron 86, 617–631 (2015)

  30. 30.

    et al. An alternative pluripotent state confers interspecies chimaeric competency. Nature 521, 316–321 (2015)

  31. 31.

    , & Oblique radial glial divisions in the developing mouse neocortex induce self-renewing progenitors outside the germinal zone that resemble primate outer subventricular zone progenitors. J. Neurosci. 31, 3683–3695 (2011)

  32. 32.

    et al. Targeted gene correction of laminopathy-associated LMNA mutations in patient-specific iPSCs. Cell Stem Cell 8, 688–694 (2011)

  33. 33.

    et al. Recapitulation of premature ageing with iPSCs from Hutchinson-Gilford progeria syndrome. Nature 472, 221–225 (2011)

  34. 34.

    , & A robust system for production of minicircle DNA vectors. Nat. Biotechnol. 28, 1287–1289 (2010)

  35. 35.

    et al. A transcription activator-like effector toolbox for genome engineering. Nat. Protocols 7, 171–192 (2012)

  36. 36.

    , & Production, concentration and titration of pseudotyped HIV-1-based lentiviral vectors. Nat. Protocols 4, 495–505 (2009)

  37. 37.

    et al. Modelling Fanconi anemia pathogenesis and therapeutics using integration-free patient-derived iPSCs. Nat. Commun. 5, 4330 (2014)

  38. 38.

    , & Transferring genes into cultured mammalian embryos by electroporation. Dev. Growth Differ . 50, 485–497 (2008)

  39. 39.

    , & Renal press-mediated transfection method for plasmid DNA and siRNA to the kidney. Biochem. Biophys. Res. Commun. 372, 383–387 (2008)

  40. 40.

    , & Intravenous injections in neonatal mice. J. Vis. Exp. e52037 (2014)

  41. 41.

    , & Isolation of muscle stem cells by fluorescence activated cell sorting cytometry. Methods Mol. Biol . 798, 53–64 (2012)

  42. 42.

    , , & Isolation and analysis of single cells from the mouse heart. J. Immunol. Methods 393, 74–80 (2013)

  43. 43.

    et al. DNA targeting specificity of RNA-guided Cas9 nucleases. Nat. Biotechnol. 31, 827–832 (2013)

  44. 44.

    & Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754–1760 (2009)

  45. 45.

    , & The relationship between full field electroretinogram and perimetry-like visual thresholds in RCS rats during photoreceptor degeneration and rescue by cell transplants. Vision Res. 44, 9–18 (2004)

Download references


We are grateful to M. Kay, Z. Y. Chen, G. Lemke and P. G. Burrola for sharing experimental materials; J. Naughton, L. Lisowski and J. Marlett for AAV production; C. Fine, J. Olvera, E. O’Connor and K. E. Marquez for cell sorting; D. Okamura and M. Jacobs for mouse surgery and histology processing; D. Skowronska-Krawczyk for rat experiments; N. V. Gohad, T. Whitfield, I. M. Verma, J. Ogawa, T. Hara, U. Manor and J. Santini for imaging; L. Greg, Y. S. Kida and F. Osakada for valuable discussions; D. O’Keefe for proofreading the manuscript and M. Schwarz for administrative help. Core Facilities were utilized at the Salk Institute (support from: NIH-NCI CCSG: P30 014195, NINDS R24NS092943, and NEI P30 EY019005) and UCSD Neuroscience core grant P30 NS047101. R.H.B. was supported by a CONACYT fellowship of Mexico. J.Z. and T.J. were supported by 973 Program (2013CB967504, 2015CB964600) and 863 Program (2014AA021604). T.H. was partially supported by a Nomis Foundation Fellowship. E.J.K. is a Biogen-IDEC Fellow of the Life Science Research Foundation. M.Y. was partially supported by the Salk Women & Science Special Award. X.F. was supported by NSFC (No. 81601872). G.H.L. and J.Q. were supported by the National Basic Research Program of China (973 Program; 2015CB964800, 2014CB910503, 2013CB967504), National Natural Science Foundation of China (81625009, 81371342, 81271266), the National High Technology Research and Development Program of China (2015AA020307, 2014AA021604), and Program of Beijing Municipal Science and Technology Commission (Z151100003915072). F.M. was supported by RIKEN funding for Development and Regeneration. Ku.Z. was supported by NIH grant R01HL123755. P.J.M. and J.C.I.B. were supported by the King Abdullah University of Science and Technology (KAUST) Office of Sponsored Research (OSR) under award no. OSR-2015-CRG4-2631. Work in the laboratory of J.C.I.B. was supported by The Leona M. and Harry B. Helmsley Charitable Trust (2012-PG-MED002), the G. Harold and Leila Y. Mathers Charitable Foundation, NIH (R01HL123755), The McKnight Foundation, The Moxie Foundation, Fundacion Dr. Pedro Guillen and Universidad Católica San Antonio de Murcia (UCAM).

Author information

Author notes

    • Keiichiro Suzuki
    • , Yuji Tsunekawa
    • , Reyna Hernandez-Benitez
    •  & Jun Wu

    These authors contributed equally to this work.


  1. Gene Expression Laboratory, Salk Institute for Biological Studies, 10010 N. Torrey Pines Rd, La Jolla, California 92037, USA

    • Keiichiro Suzuki
    • , Reyna Hernandez-Benitez
    • , Jun Wu
    • , Fumiyuki Hatanaka
    • , Mako Yamamoto
    • , Toshikazu Araoka
    • , Masakazu Kurita
    • , Tomoaki Hishida
    • , Mo Li
    • , Emi Aizawa
    • , April Goebl
    • , Rupa Devi Soligalla
    • , Concepcion Rodriguez Esteban
    •  & Juan Carlos Izpisua Belmonte
  2. Laboratory for Cell Asymmetry, RIKEN Center for Developmental Biology, 2-2-3 Minatojima-Minamimachi, Chuo-ku, Kobe 650-0047, Japan

    • Yuji Tsunekawa
    •  & Fumio Matsuzaki
  3. 4700 King Abdullah University of Science and Technology (KAUST) Thuwal 23955-6900, Saudi Arabia

    • Reyna Hernandez-Benitez
    •  & Pierre Magistretti
  4. Universidad Católica San Antonio de Murcia (UCAM) Campus de los Jerónimos, no. 135 Guadalupe 30107, Murcia, Spain

    • Jun Wu
    • , Toshikazu Araoka
    • , Jeronimo Lajara
    • , Estrella Nuñez-Delicado
    •  & Pedro Guillen
  5. Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, Guangzhou 510623, China

    • Jie Zhu
    • , Xin Fu
    •  & Kang Zhang
  6. Shiley Eye Institute, Institute for Genomic Medicine, Institute of Engineering in Medicine, University of California, San Diego, 9500 Gilman Drive #0946, La Jolla, California 92023, USA

    • Jie Zhu
    • , Tingshuai Jiang
    • , Xin Fu
    • , Maryam Jafari
    •  & Kang Zhang
  7. Systems Neurobiology Laboratory, Salk Institute for Biological Studies, 10010 N. Torrey Pines Rd., La Jolla, California 92037, USA

    • Euiseok J. Kim
    •  & Edward M. Callaway
  8. Bioengineering, University of California, San Diego, 9500 Gilman Drive, MC0412, La Jolla, California 92093-0412, USA

    • Zhe Li
    • , Shicheng Guo
    • , Song Chen
    •  & Kun Zhang
  9. State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China

    • Jing Qu
  10. University of Chinese Academy of Sciences, Beijing 100049, China

    • Jing Qu
    •  & Guang-Hui Liu
  11. Guangzhou EliteHealth Biological Pharmaceutical Technology Company Ltd, Guangzhou 510005, China

    • Tingshuai Jiang
  12. Salk Institute for Biological Studies, 10010 N. Torrey Pines Rd, La Jolla, California 92037, USA

    • W. Travis Berggren
  13. Fundación Dr. Pedro Guillen, Investigación Biomedica de Clinica CEMTRO, Avenida Ventisquero de la Condesa, 42, 28035 Madrid, Spain

    • Pedro Guillen
  14. Hospital Clinic, University of Barcelona, IDIBAPS, 08036 Barcelona, Spain

    • Josep M. Campistol
  15. National Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China

    • Guang-Hui Liu
  16. Key Laboratory of Regenerative Medicine of Ministry of Education, Institute of Aging and Regenerative Medicine, Jinan University, Guangzhou 510632, China

    • Guang-Hui Liu
  17. Beijing Institute for Brain Disorders, Beijing 100069, China

    • Guang-Hui Liu
  18. Molecular Medicine Research Center, West China Hospital, Sichuan University, Chengdu 610041, China

    • Kang Zhang
  19. Veterans Administration Healthcare System, San Diego, California 92093, USA

    • Kang Zhang


  1. Search for Keiichiro Suzuki in:

  2. Search for Yuji Tsunekawa in:

  3. Search for Reyna Hernandez-Benitez in:

  4. Search for Jun Wu in:

  5. Search for Jie Zhu in:

  6. Search for Euiseok J. Kim in:

  7. Search for Fumiyuki Hatanaka in:

  8. Search for Mako Yamamoto in:

  9. Search for Toshikazu Araoka in:

  10. Search for Zhe Li in:

  11. Search for Masakazu Kurita in:

  12. Search for Tomoaki Hishida in:

  13. Search for Mo Li in:

  14. Search for Emi Aizawa in:

  15. Search for Shicheng Guo in:

  16. Search for Song Chen in:

  17. Search for April Goebl in:

  18. Search for Rupa Devi Soligalla in:

  19. Search for Jing Qu in:

  20. Search for Tingshuai Jiang in:

  21. Search for Xin Fu in:

  22. Search for Maryam Jafari in:

  23. Search for Concepcion Rodriguez Esteban in:

  24. Search for W. Travis Berggren in:

  25. Search for Jeronimo Lajara in:

  26. Search for Estrella Nuñez-Delicado in:

  27. Search for Pedro Guillen in:

  28. Search for Josep M. Campistol in:

  29. Search for Fumio Matsuzaki in:

  30. Search for Guang-Hui Liu in:

  31. Search for Pierre Magistretti in:

  32. Search for Kun Zhang in:

  33. Search for Edward M. Callaway in:

  34. Search for Kang Zhang in:

  35. Search for Juan Carlos Izpisua Belmonte in:


K.S., Y.T., R.H.B., J.W. and J.C.I.B. conceived the project and designed experiments. K.S., Y.T. and E.A. constructed plasmids. K.S., R.H.B., M.Y. and M.L. generated minicircle DNA vectors. K.S., Y.T., R.H.B., M.L., E.A., A.G. and R.D.S. performed work on HEK293 cells. K.S., Y.T., R.H.B. and E.A. performed bisulfite sequencing. K.S., Y.T. and R.H.B. measured intracellular localization of dCas9. K.S. and Y.T. performed the Surveyor assay. R.H.B. performed work on primary neurons. K.S., Y.T., R.H.B., E.A. and A.G. performed work on human ES-cell-derived pan neurons. Y.T. and F.M. performed work on in utero electroporation. J.Z., T.J., X.F., M.J. and Ka.Z. performed work on RCS rats. E.J.K. and E.M.C. performed work on adult mouse brain. F.H., T.A., M.K. and T.H. performed in vivo mouse electroporation. F.H., M.Y. and T.A. performed AAV IV and IM injection in neonatal or adult mice. Z.L., S.G., S.C. and Ku.Z. performed deep sequencing and analysed data. K.S. and E.A. performed single-cell genotyping. J.W., J.Q., C.R.E, W.T.B., J.L., E.N.D., P.G., J.M.C., G.H.L., P.M. and J.C.I.B. supervised the project or related experiments. K.S., Y.T., J.W. and J.C.I.B. wrote the manuscript with input from all the authors.

Competing interests

The authors declare no competing financial interests.

Corresponding author

Correspondence to Juan Carlos Izpisua Belmonte.

Reviewer Information Nature thanks M. Porteus and the other anonymous reviewer(s) for their contribution to the peer review of this work.

Extended data

Supplementary information

PDF files

  1. 1.

    Supplementary Information

    This file contains the uncropped gels for Figures 3d, 4c and Extended Data Figures 1b, 2a, 3d, 4f, 5c, f, 7d


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.